PHARMACY

Ranbaxy retains Giuliani on FDA matter

BY Alaric DeArment

PRINCETON, N.J. Ranbaxy Laboratories has hired former New York City mayor and former presidential candidate Rudy Giuliani and his law firm, Giuliani Partners, to provide advice and review compliance issues related to the warning letters and import advisory it recently received from the Food and Drug Administration, the Indian drug maker announced Wednesday.

The company also said it would work with the FDA to address the import advisory and put measures into place that would allow its products listed in the advisory to be released in the United States.

The FDA has said that all of Ranbaxy’s drugs have repeatedly tested safe and effective with no adverse incidents reported.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Care Pharmacies joins NCPA

BY Michael Johnsen

ALEXANDRIA, Va. Care Pharmacies on Wednesday announced that the franchise network of more than 50 independent pharmacies joined the National Community Pharmacists Association.

“As an advocate for our cause, NCPA is one of our biggest allies, and as they support us, we should support them,” stated Care chief executive officer Gerry Crocker.

Care and NCPA has shared office space since February, when the franchisor relocated its offices to the NCPA headquarter building as part of its planned expansion efforts.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Bayer to acquire Direvo Biotech for $300 million

BY Alaric DeArment

NEW YORK Bayer has announced that it will buy a German biotech company for almost $300 million.

Bayer said in a statement that the deal to buy Direvo Biotech would likely be done at the end of the month.

The acquisition will help Bayer’s efforts to develop biologic drugs, including antibodies.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?